CoChat

Deep Learning Algorithm Trained with COVID-19 Pneumonia Also Identifies Immune Checkpoint Inhibitor Therapy-Related Pneumonitis

Open access

The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.

Abstract

Background: Coronavirus disease 2019 (COVID-19) pneumonia and immune checkpoint inhibitor (ICI) therapy-related pneumonitis share common features. The aim of this study was to determine on chest computed tomography (CT) images whether a deep convolutional neural network algorithm is able to solve the challenge of differential diagnosis between COVID-19 pneumonia and ICI therapy-related pneumonitis. Methods: We enrolled three groups: a pneumonia-free group (n = 30), a COVID-19 group (n = 34), and a group of patients with ICI therapy-related pneumonitis (n = 21). Computed tomography images were analyzed with an artificial intelligence (AI) algorithm based on a deep convolutional neural network structure. Statistical analysis included the Mann–Whitney U test (significance threshold at p < 0.05) and the receiver operating characteristic curve (ROC curve). Results: The algorithm showed low specificity in distinguishing COVID-19 from ICI therapy-related pneumonitis (sensitivity 97.1%, specificity 14.3%, area under the curve (AUC) = 0.62). ICI therapy-related pneumonitis was identified by the AI when compared to pneumonia-free controls (sensitivity = 85.7%, specificity 100%, AUC = 0.97). Conclusions: The deep learning algorithm is not able to distinguish between COVID-19 pneumonia and ICI therapy-related pneumonitis. Awareness must be increased among clinicians about imaging similarities between COVID-19 and ICI therapy-related pneumonitis. ICI therapy-related pneumonitis can be applied as a challenge population for cross-validation to test the robustness of AI models used to analyze interstitial pneumonias of variable etiology.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/cancers13040652

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Flowchart of the model training process and a diagram to show how the artificial intelligence (AI) model works to generate a prediction risk of disease.
Figure 1 Flowchart of the model training process and a diagram to show how the artificial intelligence (AI) model works to generate a prediction risk of disease.CC BY · PubMed Central
Figure 2 Receiving operating curves (ROC) of the diagnostic performance of the AI prediction risk of COVID-19 pneumonia. Each plot shows the ROC obtained during testing after including the pairs: COVID-19 and pneumonia-free patients (A), COVID-19 and ICI-related therapy (B) and ICI-related therapy, and pneumonia-free patients (C). Gray lines plot 95% confidence intervals. COVID-19 = coronavirus disease 2019. ICI = immune checkpoint inhibitor. AUC = area under ROC. Std. Error = standard error.
Figure 2 Receiving operating curves (ROC) of the diagnostic performance of the AI prediction risk of COVID-19 pneumonia. Each plot shows the ROC obtained during testing after including the pairs: COVID-19 and pneumonia-free patients (A), COVID-19 and ICI-related therapy (B) and ICI-related therapy, and pneumonia-free patients (C). Gray lines plot 95% confidence intervals. COVID-19 = coronavirus disease 2019. ICI = immune checkpoint inhibitor. AUC = area under ROC. Std. Error = standard error.CC BY · PubMed Central
Figure 3 Computed tomography (CT) images of patients with RT-PCR-proven COVID-19 pneumonia (upper panel) and ICI therapy-related pneumonitis (lower panel). Axial CT images with lung window (left side of upper and lower panel) and 3D volume rendering technique (VRT) images (right side of upper and lower panel) are shown. Note the overlapping CT features of ground-glass opacities between the two cases of different etiology.
Figure 3 Computed tomography (CT) images of patients with RT-PCR-proven COVID-19 pneumonia (upper panel) and ICI therapy-related pneumonitis (lower panel). Axial CT images with lung window (left side of upper and lower panel) and 3D volume rendering technique (VRT) images (right side of upper and lower panel) are shown. Note the overlapping CT features of ground-glass opacities between the two cases of different etiology.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 37 references

Cited by

See all 30

Metadata

Authors
Mallio, C. A., Napolitano, A., Castiello, G., Giordano, F. M., D'Alessio, P., Iozzino, M., Sun, Y., Angeletti, S., Russano, M., Santini, D., Tonini, G., Zobel, B. B., Vincenzi, B., & Quattrocchi, C. C.
Affiliations
  • Università Campus Bio-Medico (IT)
  • Departmental Faculty of Medicine and Surgery, Unit of Medical Oncology, 00128 Rome, Italy
  • Departmental Faculty of Medicine and Surgery, Unit of Diagnostic Imaging and Interventional Radiology, Università Campus Bio-Medico di Roma, 00128 Rome, Italy
  • Ospedale Santa Maria Goretti (IT)
  • Infervision Europe GmbH, Mainzer Strasse 75, D-65189 Wiesbaden, Germany
Corresponding author
  • Mallio, Carlo Augusto
  • Napolitano, Andrea
Venue
Cancers
Publisher
MDPI AG
Published
2021-02-06
Volume
13
Issue
4
Pages
652
ISSN
2072-6694 (ISSN-L)
OpenAlex
W3126423192
Cited by
30
References
36
Citations by year
2026: 1 · 2025: 6 · 2024: 3 · 2023: 8 · 2022: 5 · 2021: 7
FWCI
3.04
Type
journal article
Language
en
Open access
Locations
  • Cancers (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • IRIS Research product catalog (Sapienza University of Rome) (submittedVersion, cc-by)
  • Iris (University of Trento) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › COVID-19 diagnosis using AI
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiomics and Machine Learning in Medical Imaging
  • Health Sciences › Medicine › Health Informatics › Artificial Intelligence in Healthcare and Education
Keywords
COVID-19 pneumonia, immune-related pneumonitis, differential diagnosis, chest CT, deep convolutional neural networks, artificial intelligence, interstitial lung disease, model robustness, cross-validation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Deep Learning Algorithm Trained with COVID-19 Pneumonia Also Identifies Immune Checkpoint Inhibitor Therapy-Related Pneumonitis. https://app.cochat.ai/papers/10.3390/cancers13040652
The paper
Mallio, C. A., Napolitano, A., Castiello, G., Giordano, F. M., D'Alessio, P., Iozzino, M., Sun, Y., Angeletti, S., Russano, M., Santini, D., Tonini, G., Zobel, B. B., Vincenzi, B., & Quattrocchi, C. C. (2021). Deep Learning Algorithm Trained with COVID-19 Pneumonia Also Identifies Immune Checkpoint Inhibitor Therapy-Related Pneumonitis. Cancers. https://doi.org/10.3390/cancers13040652

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.